Membranoproliferative Glomerulonephritis Treatments
Find Membranoproliferative Glomerulonephritis Treatments
Medications for Membranoproliferative Glomerulonephritis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Membranoproliferative Glomerulonephritis.
Found 1 Approved Drug for Membranoproliferative Glomerulonephritis
Pegcetacoplan
Brand Names
Empaveli, Syfovre
Pegcetacoplan
Brand Names
Empaveli, Syfovre
Form: Injection
Method of administration: Subcutaneous, Intravitreal
FDA approval date: May 14, 2021
Classification: Complement Inhibitor
SYFOVRE is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). SYFOVRE is a complement inhibitor indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances